FRI047 Clinical Characteristics Of Patients With Morbid Obesity With Semaphorines (SEMA3D,E,G) And PLXNA3&4 Gene Variants

Disclosure: M. Berra: None. A. Khattab: None. S.B. Ten: None. A.S. Bhangoo: None. Aim of the study: To describe the clinical characteristics of patients with morbid obesity with SEMA3D,E,G and PLXNA3&4 gene variants. Introduction: Heterozygous variants of SEMA3s and their receptors PLXNA3 and 4...

Descripción completa

Detalles Bibliográficos
Autores principales: Berra, Maddie, Khattab, Ahmed, Ten, Svetlana B, Bhangoo, Amrit Pal S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Adipose Tissue, Appetite, & Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553692/
http://dx.doi.org/10.1210/jendso/bvad114.058

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10553692/
http://dx.doi.org/10.1210/jendso/bvad114.058

Ejemplares similares